Supreme Court Review: Protect Access to Mifepristone Medication

The Supreme Court's upcoming review of the mifepristone case is of utmost importance. The decision will directly impact the accessibility of this crucial medication. The FDA's current rules, allowing telemedicine appointments and mail prescriptions, have made it more accessible, particularly for those who may face barriers to in-person healthcare. The nationwide ban imposed in Texas contradicts this progress. It is essential to uphold the FDA's current rules to ensure that everyone, regardless of their location or circumstances, can access the healthcare they need. The court's decision should prioritize the bodily autonomy of all individuals. The future accessibility of mifepristone is at stake, and it is crucial to ensure that this medication remains within reach for those who need it.